Abcellera Biologics (ABCL)Baker Bros. Advisors LP added to its stake +2.74M shares
Baker Bros. Advisors LP added to its stake in Abcellera Biologics, per its Q2 2026 13F.
- 33M
- Shares reported · +2.74M vs prior quarter
- 1.3%
- Disclosed portfolio weight
- $259M
- Reported value
- Holdings as of
- Jun 30, 2026
- Filed
- Aug 14, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 30, 2026, the Board of Directors (the "Board") of AbCellera Biologics Inc. (the "Company") appointed Lynn Seely, M.D as a new Class III director. Dr. Seely will serve until the Company’s 2029 annual meeting of shareholders and until her successor is duly elected and qualified, or until her earlier resignation or removal..”
- Aug 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Aug 12, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Abcellera Biologics
For Abcellera Biologics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABCL page.
How this filing works
Other disclosures at Abcellera Biologics
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRNov 14, 2025
- SEC Form 13F-HRAug 14, 2025
- SEC Form 4Mar 11, 2025
- SEC Form 4Mar 10, 2025
- SEC Form 4Mar 7, 2025
Everything OQRO holds on this company is on its ABCL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data